[144] Adaptive Biotechnologies Corp SEC Filing
Rhea-AI Filing Summary
Harlan Robins reported sales of common stock under Form 144, indicating dispositions of 100,000 and 10,000 shares. The filing notes the securities were acquired as Performance Awards on 03/07/2026. Transaction proceeds shown are $1,737,460 and $148,323.94.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice of insider dispositions with compensation-origin securities.
The filing lists proposed and recent dispositions by Harlan Robins: securities were acquired as Performance Awards on 03/07/2026 and 100,000 and 10,000 shares are reported as sold in the recent period. The filing follows the mechanics typical for restricted securities sales.
Timing, method of sale, and any transfer restrictions are not detailed in the excerpt; subsequent filings or trade reports may provide execution specifics and broker arrangements.
Transaction scale: two reported dispositions totaling 110,000 shares with documented proceeds.
The excerpt shows cash amounts of $1,737,460 for 100,000 shares and $148,323.94 for 10,000 shares, reflecting executed sales during the past three months. The noted acquisition source is compensation (performance awards).
Market impact depends on free float context not provided here; additional exchange or brokerage reports would clarify execution method and timing.